SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950135-07-002152
Filing Date
2007-04-09
Accepted
2007-04-09 16:59:40
Documents
12
Period of Report
2007-05-17
Effectiveness Date
2007-04-09

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS b63762dfdef14a.htm DEF 14A 507935
2 GRAPHIC b63762dfb6376200.gif GRAPHIC 2773
3 GRAPHIC b63762dfb6376201.gif GRAPHIC 856
4 GRAPHIC b63762dfb6376204.gif GRAPHIC 1381
5 GRAPHIC b63762dfb6376202.gif GRAPHIC 2400
6 GRAPHIC b63762dfb6376205.gif GRAPHIC 1657
7 GRAPHIC b63762dfb6376203.gif GRAPHIC 743
8 GRAPHIC b63762dfb6376206.gif GRAPHIC 1077
9 GRAPHIC b63762dfb6376207.gif GRAPHIC 737
10 GRAPHIC b63762dfb6376208.gif GRAPHIC 800
11 GRAPHIC b63762dfb6376209.gif GRAPHIC 1080
12 GRAPHIC b63762dfb6376210.gif GRAPHIC 1784
  Complete submission text file 0000950135-07-002152.txt   532185
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

IRS No.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-16789 | Film No.: 07756820
SIC: 2835 In Vitro & In Vivo Diagnostic Substances